Company page
Stemcyte International Ltd.
Stemcyte International Ltd. is a public company traded on the Taiwan stock market under the ticker 4178. The company has a market capitalization of approximately NT$127.26 million. Stemcyte focuses on advancements in stem cell technology and related healthcare solutions.
- Ticker
- 4178
- Market cap
- $127.3M
- Sector
- Health Services
- Industry
- Medical/Nursing Services